Những người này rất chắc chắn. Mọi thứ minh bạch, báo cáo đến đều đặn, và họ làm đúng những gì đã nói. Không có thông tin ẩn, tôi đã kiểm tra
NewAmsterdam Pharma Stock: Obicetrapib More Than Another LDL-Lowering Pill (NASDAQ:NAMS) | Seeking AlphaIchor Holdings: Waiting For Proof, Not A Better Price (NASDAQ:ICHR) | Seeking AlphaNoah Holdings -Strong 2Q Expected (NYSE:NOAH) | Seeking AlphaJPMorgan Chase Stock: Top Bank For Earning Power And Fortress Balance Sheet (NYSE:JPM) | Seeking AlphaCarpenter Technology Stock: From Strong Buy To Sell After A 78% Rally (NYSE:CRS) | Seeking Alpha

economy, business and finance
This is the forum for daily political discussion on Seeking Alpha. A new version is published every market day. Please don't leave political comments on other articles or posts on the site. The comments below are not regulated with the same rigor as the rest of the site, and this is an 'enter at .…

business information
A strong balance sheet supports NAMS through key clinical readouts and potential U.S. launch, mitigating near-term financing risk despite ongoing pre-commercial status. I think NewAmsterdam Pharma (NAMS) is in a promising position because I believe obicetrapib is currently being viewed as just ...
Chưa có bài viết nào
Các bài viết sẽ xuất hiện ở đây ngay sau khi được đăng tải.
